Purchase Order 12805B20P0105

The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $28,491.20 firm fixed price purchase order to New England Biolabs, Inc. for NEBNext® UltraTM II Directional RNA Library Prep Reagents. The place of performance is the prime contractor's facility in Ipswich, Massachusetts. The period of performance is from August 14, 2023 through September 29, 2023. The original solicitation sought NEBNext® UltraTM II Directional RNA...

This is a firm fixed-price delivery order awarded by the Department of Agriculture's Agricultural Research Service to Illumina, Inc., a for-profit manufacturer of genetic sequencing systems and consumables. The order is for NEXTSEQ 500/550 HI OUTPUT KITV2.5 (300CY) and other laboratory equipment and consumables, with a potential value of $313,117.42 and a completion date of May 25, 2025. No set-aside was used for this award. Illumina has a history of providing sequencing systems and related...

This is a firm fixed price contract awarded by the National Human Genome Research Institute, a civilian agency, to New England Biolabs, Inc. (NEB) for the supply of the NEBNext Ultra II Directional RNA Library Prep Kit with Purification Beads. The contract has a ceiling value of $15,112.00 and a period of performance through May 20, 2025. This appears to be a Blanket Purchase Agreement (BPA) call order, which is part of a larger $10 million single-award BPA contract between NEB and the...

This is a firm fixed price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Illumina, Inc., a manufacturer of genetic and genomic analysis instrumentation and reagents. The contract is for the delivery of NEXTSEQ 500/550 HIGH OUTPUT KIT V2.5 (300 CYCLES) at a ceiling value of $24,942.05 with a final completion date of August 29, 2024. This award does not utilize any set-aside designations. Illumina has previously been awarded prime contracts and subcontracts...

This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Illumina, Inc. for the procurement of a NEXTSEQ 500 HIGH OUTPUT KIT (300 CYCLES) with a ceiling value of $77,520.00. The award was made on August 14, 2014 with a period of performance ending September 30, 2017. This award does not have a set-aside designation. Illumina, Inc. is a manufacturer and provider of sequencing and array-based solutions for genetic and genomic analysis, and has a history of...

The Department of Health and Human Services National Institutes of Health Clinical Center awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of genetic sequencing systems and reagents, for the provision of NEXTSEQ 500/550 HIGH OUTPUT KIT V2.5 (300 CYCLES). The $24,969.00 award has a completion date of May 9, 2024. Illumina is a for-profit organization that has previously held prime federal contracts and sub-grants with agencies such as the National Institutes of...

The Department of Health and Human Services National Institutes of Health Clinical Center awarded a firm fixed price delivery order contract to Illumina, Inc., a for-profit manufacturer of genetic sequencing and analytical instruments and reagents, for the delivery of NEXTSEQ 500/550 HIGH OUTPUT KIT V2.5 (300 CYCLES) with a potential value of $19,975.20. The contract has a performance period through May 30, 2024 and was awarded on April 19, 2024 without any set-aside designation. Illumina has...

This is a delivery order issued by the U.S. Department of Agriculture's Animal and Plant Health Inspection Service (USDA APHIS) to Illumina, Inc. for the procurement of NextSeq 2000 P3 reagents and Nextera XT DNA library preparation kits. The award, valued at $23,212.14, is for the provision of these laboratory consumables to support genomic sequencing and analysis activities at the USDA APHIS National Veterinary Services Laboratories Foreign Animal Disease Diagnostic Laboratory in Orient, New...

The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $24,032 firm fixed price purchase order to New England Biolabs, Inc. for NEBNEXT ULTRA II Q5 MASTER MIX. The master mix reagent is needed to support amplification of DNA for next generation sequencing in a high-throughput chromatin assay. The sources sought notice specified a need for 40 units of the 500 reaction size product to support research activities at...

This is a firm fixed price purchase order awarded by the Department of the Army Medical Command to Illumina, Inc., a for-profit manufacturer of genetic analysis instruments and reagents. The award is for NEXTSEQ 500/550 HIGH OUTPUT KIT V2 (150) with a potential value of $159,208.19. The contract has no set-aside designation and was awarded on September 23, 2017, with a completion date of December 31, 2017. Illumina has a history of providing sequencing systems, consumables, and bioinformatics...